Christopher Verni
General Counsel en VIGIL NEUROSCIENCE, INC. .
Fortuna: 13 640 $ al 31/03/2024
Perfil
Christopher Verni is currently the General Counsel at Vigil Neuroscience, Inc. He previously worked as the Corporate Counsel-Intellectual Property at Pfizer Inc. from 2004 to 2007, as the Senior Patent Counsel at ARIAD Pharmaceuticals, Inc. from 2011 to 2013, and as the Chief Intellectual Property Officer & Senior VP at Sarepta Therapeutics, Inc. from 2013 to 2022.
Additionally, he served as the Senior Patent Counsel at Sanofi SA from 2007 to 2011.
Mr. Verni obtained his undergraduate degree from Rochester Christian University and his graduate degree from the University of New Hampshire School of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VIGIL NEUROSCIENCE, INC.
0.01% | 01/03/2024 | 4 000 ( 0.01% ) | 13 640 $ | 31/03/2024 |
Cargos activos de Christopher Verni
| Empresas | Cargo | Inicio |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | General Counsel | 20/04/2022 |
Antiguos cargos conocidos de Christopher Verni.
| Empresas | Cargo | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2022 |
| ARIAD PHARMACEUTICALS, INC. | General Counsel | 01/11/2013 |
| Sanofi SA | General Counsel | 01/10/2011 |
| PFIZER, INC. | General Counsel | 01/05/2007 |
Formación de Christopher Verni.
| Rochester Christian University | Undergraduate Degree |
| University of New Hampshire School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi SA | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Verni
